Insulin gene VNTR genotype associates with frequency and phenotype of the autoimmune response to proinsulin by Durinovic-Belló, I et al.
SHORT COMMUNICATION
Insulin gene VNTR genotype associates with frequency
and phenotype of the autoimmune response to proinsulin
I Durinovic-Bello ´, RP Wu, VH Gersuk, S Sanda, HG Shilling and GT Nepom
Benaroya Research Institute, University of Washington School of Medicine, Seattle, WA, USA
Immune responses to autoantigens are in part controlled by deletion of autoreactive cells through genetically regulated selection
mechanisms. We have directly analyzed peripheral CD4þ proinsulin (PI) 76–90 (SLQPLALEGSLQKRG)-specific T cells using
soluble fluorescent major histocompatibility complex class II tetramers. Subjects with type I diabetes and healthy controls with
high levels of peripheral proinsulin-specific T cells were characterized by the presence of a disease-susceptible polymorphism in
the insulin variable number of tandem repeats (INS-VNTR) gene. Conversely, subjects with a ‘protective’ polymorphism in the
INS-VNTR gene had nearly undetectable levels of proinsulin tetramer-positive T cells. These results strongly imply a direct
relationship between genetic control of autoantigen expression and peripheral autoreactivity, in which proinsulin genotype
restricts the quantity and quality of the potential T-cell response. Using a modified tetramer to isolate low-avidity proinsulin-specific
T cells from subjects with the susceptible genotype, transcript arrays identified several induced pro-apoptotic genes in the control,
but not diabetic subjects, likely representing a second peripheral mechanism for maintenance of tolerance to self antigens.
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Introduction
Insulin is an important antigen in both murine
1 and
human
2 autoimmune diabetes (type 1A diabetes (T1D)).
T-cell reactivity to a major proinsulin epitope, PI(73–90),
occurs as an early marker of disease progression in the
pre-diabetic stage among genetically high-risk subjects.
2,3
Direct detection of these proinsulin-specific T cells was
recently achieved using soluble, fluorescent human
leukocyte antigen (HLA)-peptide tetramers containing
the PI(73–90) epitope to bind to peripheral CD4 T cells
proliferating in response to proinsulin peptide stimula-
tion.
4 In humans, expression levels of insulin are
regulated in part by a direct transcriptional influence of
a polymorphic insulin gene variable number of tandem
repeats (INS-VNTR) genetic element associated with the
proinsulin gene promoter region. Higher expression
levels of proinsulin, due to the presence of the VNTR
III haplotype in the thymus, are associated with a 3- to
4-fold relative protection from diabetes.
5–7 Using proin-
sulin-specific HLA tetramers to detect CD4 T cells in
subjects with either the VNTR III protective haplotype or
the allelic VNTR I diabetes susceptibility haplotype,
we found markedly lower frequencies of high-avidity
T cells in VNTR III-positive subjects, consistent with a
genetically controlled mechanism of immune tolerance
based on polymorphic antigen expression levels in-
volved in thymic selection of autoreactive lymphocytes.
In human autoimmune diseases many epitopes recog-
nized by autoreactive T cells are of moderate or low
avidity,
8–10 which may allow these cells to escape
deletional tolerance mechanisms during thymic devel-
opment. Expression of proinsulin, similar to other tissue-
specific protein antigens, occurs in thymic medullary
epithelial cells influenced by the transcriptional regulator
AIRE (autoimmune regulator),
11 and NOD mice deficient
in thymic insulin expression have accelerated develop-
ment of T1D, consistent with escape of high-avidity
autoreactive T cells and a prominent role for central
tolerance in protection from insulin autoimmunity.
12,13
Transcriptional levels of proinsulin in the human thymus
are under genetic control of the polymorphic INS
promoter region, which carries a variable number of
tandem repeats of a 14-bp consensus element, classified
as VNTR I (short, 26–63 repeats), VNTR II (63–140
repeats) or VNTR III (long, 141–209 repeats). European
ancestry populations express either VNTR I or III,
14 and
insulin transcription in thymic tissue is higher in VNTR
I/III heterozygotes or VNTR III/III homozygotes when
compared with VNTR I/I homozygotes.
15,16
Allelic variation at INS-VNTR confers differential
susceptibility to T1D. Subjects with the VNTR III genotype
have a lower frequency of anti-insulin autoantibodies,
17
more preserved b-cell function
18 and a lower concordance
rate of diabetes among twins
19 when compared with
subjects having the VNTR I/I genotype. Overall, the
INS-VNTR genotype is associated with an odds ratio
for T1D susceptibility of 2.2,
20 and the presence of the
VNTR III genotype can moderate disease risk, even in
populations that carry high-risk HLA genotypes.
21
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One postulated mechanism to account for the T1D
protective effect of VNTR III is that higher thymic
expression may lead to deletion of proinsulin-reactive
Tcells during development. To directly test this hypothesis,
we analyzed peripheral blood lymphocytes for recogni-
tion of HLA class II-proinsulin complexes in subjects
with VNTR I/I or VNTR III/x (where x¼I or III)
genotypes. CD4þCD25– peripheral T lymphocytes from
24 Caucasian VNTR I/I and 21 VNTR III/x subjects
matched for HLA-DRB1*0401 were cultured with
autologous antigen-presenting cells in the presence of
PI(76–90),
22 to allow for expansion of antigen-specific
cells, and subsequently incubated with soluble
DRB1*0401-PI(76–90) complexes conjugated to a phy-
coerythrin fluorochrome. Out of 45 HLA-DRB1*0401-
positive subjects analyzed, 6 were homozygous for
DRB1*0401, 12 had in addition DRB1*0301 and the
remaining 27 had some other DRB1* allele. The PI 73–90
epitope is immunodominant in both humans and in
humanized HLA-DR4/CD4 double-transgenic mice
immunized with human proinsulin.
23 Of VNTR I/I
subjects, 79% (19/24) had detectable tetramer-positive
T cells, compared with 29% (6/21) of the VNTR III/x
subjects (Po0.0010; Table 1). As shown in Figure 1a, the
difference in overall distribution of tetramer positivity
was highly significant between groups (Po0.0004) and,
with two exceptions, all the VNTR III/x subjects were at
or near background levels of tetramer detection.
To improve the detection of low-avidity CD4þ self-
reactive T cells in T1D, HLA class II tetramer reagents
have been developed with agonist peptides containing
amino acid substitutions, which improve binding of the
tetramer to the antigen-specific regulatory T cells. Yang
et al.
4 recently described substitution of lysine to serine at
peptide position p9 within the PI(76–90) peptide to
stabilize binding to DRB1*0401 in soluble tetramers,
resulting in enhanced detection of a proinsulin-positive
CD4 T-cell population. When the same T-cell samples
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Figure 1 Relationship between INS-VNTR genotype and detection of CD4 Tcells, which bind PI76–90 tetramers. Subjects with VNTR class I
alleles have high levels of peripheral blood T cells recognizing soluble DRB1*0401-PI76–90 tetramer compared with the subjects having the
protective class III alleles (a). The same T-cell samples were analyzed using the PI76–90 9S modified tetramer; no difference between the two
groups of subjects was detected, implying presence of low-avidity PI-reactive T cells in both (b). In addition, no difference in tetramer
positivity between the two groups of subjects was found when tetramers specific for another T1D autoantigen, GAD555–567, or foreign
antigen, HA306–318, were used, indicating proinsulin specificity of the VNTR association (c, d). ***P¼0.0004, differences in the level of
tetramer-reactive Tcells were calculated using Mann–Whitney U test. Solid horizontal lines represent means. Dashed horizontal lines indicate
0.5% binding of negative control tetramer.
$INS-VNTR III/x where x¼I or III. Typing for HLA-DRB1*04 subtypes was performed using
sequence-specific primers and probes in conjunction with real-time PCR.
27 A total of 45 HLA-DRB1*0401-positive subjects were analyzed out
of which 6 were homozygous for DRB1*0401, 12 had in addition DRB1*0301 and the remaining 27 had in addition some other DRB1* allele.
T1D patients of INS-VNTR I/I as well as INS-VNTR I/III genotype were of comparable age (average 25.8±8.9 years vs 26.2±11.6 years,
respectively) and had similar duration of the disease (3.4±1.9 years vs 5.5±1.5 years, respectively) as were autoantibody-positive subjects
(36.3±10.4 vs 42±12.8) and healthy controls (40.4±14.5 vs 50.5±14.6). The VNTR genotype was assigned based on the genotype at the  23
A/T single-nucleotide polymorphism (SNP) at the INS promoter.
14,28 Peripheral blood mononuclear cells were isolated from heparinized
blood and CD4þCD25  Tcells enriched in two steps. In the first step CD4þ Tcells were separated from all non-CD4 cells using CD4þ T
cell isolation kit (Miltenyi Biotec, Auburn, CA, USA). In the second step CD25þ Tcells were depleted using anti-CD25-coated micro beads.
CD4þCD25  T cells were stimulated in vitro for 12–14 days in 48-well tissue culture plates with autologous adherent non-CD4þ cells
prepulsed with either PI peptides, hemagglutinin (HA) peptide (10mgml
 1) or without peptides. At days 6, 8 and 10, human recombinant
IL-2 (10IUml
 1, Chiron Corporation, Emeryville, CA, USA) was added to the cultures.
Table 1 Occurrence of PI76–90 tetramer-positive
a cells in T1D
patients and non-T1D subjects
INS-VNTR PI76–90 tetramer
positive % (x/y)
bP VNTR
I/I vs III/x
P groups
T1D I/I 88 (14/16) 0.0581
III/x 44 (4/9)
Ab+ I/I 67 (2/3) NS 0.0665
III/x 17 (1/6)
Controls I/I 60 (3/5) NS
III/x 17 (1/6)
T1D and
Ab+
I/I 84 (16/19) 0.0042
III/x 33 (5/15)
All I/I 79 (19/24) 0.0010
III/x 29 (6/21)
Abbreviations: Ab+, autoantibody positive; INS-VNTR, insulin
variable number of tandem repeats; INS-VNTR III/x, III/I or
III/III; NS, not significant; PI, proinsulin; T1D, type IA diabetes.
aTetramer positivity was defined as 40.5% of the negative control
tetramer. Differences in tetramer positivity between the groups
were calculated using Fisher’s exact test and considered significant
at Po0.05.
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Genes and Immunitywere analyzed using this ‘9S’ tetramer, higher levels of
tetramer-positive cells were detected, in both VNTR I/I
and VNTR III/x subjects (Figure 1b), and there was no
difference between groups. Thus, low-avidity T cells are
present in both populations, independent of genotype,
whereas the presence of CD4 T cells with higher avidity,
capable of recognizing the native proinsulin peptide, is
under INS genetic control.
Parallel tetramer assays were performed using either
another T1D autoantigen, GAD65,
24 or an antigen from
the hemagglutinin of influenza virus.
25 As shown in
Figures 1c and d, no differences in tetramer positivity for
these antigens were found among subjects classified by
INS-VNTR genotype, indicating specificity for the
proinsulin immune response.
The lymphocyte samples for these assays come from a
mixture of T1D subjects, autoantibody-positive, non-
diabetic ‘at-risk’ subjects and non-autoimmune controls.
INS-VNTR genetic control of T-cell detection using
proinsulin tetramers was similar in all three groups, as
summarized in Table 1. In other words, the correlation
between INS-VNTR and the presence of peripheral
proinsulin tetramer-binding T cells was found in all
groups based on genotype alone, irrespective of disease
status. Overall, combining VNTR I/I and VNTR III/x
subjects, there was also a trend for higher tetramer
positivity in the T1D group when compared with
the non-diabetic groups, consistent with the presence
of pre-existing in vivo expansion of autoreactive cells in
the diabetic population (Supplementary Figure S1).
Alternatively, the in vitro culture conditions of the assay
may allow for preferential expansion of these auto-
reactive populations.
As tetramer-binding studies with the modified ‘9S’
peptide allowed us to detect low-avidity PI(76–90)-
binding T cells, we used HLA-DRB1*0401–9S tetramers
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Figure 2 Flow cytometry profiles of CD4 T cells of T1D and control subjects used for RNA isolation and subsequent transcript arrays,
showing tetramer binding with the PI 76–90 9S modified tetramer. Parallel HA306–319 tetramer-positive binding (foreign control antigen)
and an irrelevant control tetramer, outer surface protein A (OspA) 163–175, are also shown. The numbers in the upper right quadrant
represent percentages of the tetramer-positive cells in the CD4þCD25  T-cell subset after 14 days of culture. Major histocompatibility
complex (MHC) class II tetramers were produced by constructing the expression vectors and generating soluble biotinylated HLA-
DRB1*0401 molecules, as described elsewhere.
25 HLA molecules were loaded with peptides by detergent-facilitated exchange and dialyzed to
remove the unbound fractions. Tetramers were obtained by incubation with phycoerythrin-labeled streptavidin. PI76–90 immunodominant
epitope (SLQPLALEGSLQKRG),
22 a PI76–90 9S substitute peptide (SLQPLALEGSLQSRG), in which substitution of K88 to S in peptide
position 9 (9P) enhanced its binding affinity and agonistic activity,
4,22 and two irrelevant control peptides, an influenza A hemagglutinin,
HA306–318 (KYVKQNTLKLA)
25 as a positive control and Borrelia burgdorferi OspA163–175 (KSYVLEGTLTAEK) as a negative control were
each loaded into HLA-DR4 molecules assembled into tetramers. After 12–14 days of culture, T cells were stained with tetramers for flow
cytometry analysis as described.
29
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Genes and Immunityfor sorting of the proinsulin-specific CD4 T cells by flow
cytometry from INS-VNTR I/I subjects. The recovery
of cells was limited because of the low frequency of
antigen-specific T cells, but in four cases (two controls
and two T1D) we purified sufficient tetramer-positive
cells for transcript array analysis. Figure 2 shows the
flow cytometry profiles used for cell sorting: parallel
tetramer sorting of the influenza hemagglutinin-positive
T cells and parallel transcript arrays from the same
samples used as controls.
Of the 84 transcripts selected for cytokines and
candidate immunologic markers, 6 clearly distinguished
between the proinsulin tetramer-positive cells of the
normal control subjects and T1D subjects (Figure 3). Four
of these markers are closely related, representing pro-
apoptotic transcripts associated with peripheral toler-
ance mediated by activation-induced cell death: FASLG
(Fas ligand (TNF superfamily, member 6)), interleukin-2
(IL-2), tumor necrosis factor and TNFSF11 (TNF (ligand)
superfamily, member 11). These markers were observed
in both normal and T1D subjects responding to a foreign
antigen, but only in the normal subjects responding to
proinsulin. The failure to upregulate these transcripts in
the T1D T cells activated by proinsulin may indicate a
functional resistance to this pathway of peripheral
tolerance.
In addition, there were two marker transcripts, IL-10
and IL-7, that were upregulated in the T1D subjects but
not in the normal controls responding to proinsulin. The
presence of IL-10 transcripts in the T cells from T1D
subjects responding to proinsulin is of interest because
this is reminiscent of previous studies in which periph-
eral blood stimulation with proinsulin peptides was
predominantly associated with IL-10 release.
22,26 Figure 4
illustrates mixed T-cell proliferation assays, in which
three T-cell clones purified from the sorted ‘9S’ proinsu-
lin tetramer-positive population were added to auto-
logous responder peripheral blood mononuclear cells. In
each case, suppression of the bystander T cells, irrespec-
tive of additional antigen, was observed. It is possible
that IL-10 and IL-7 are associated with cell survival and
anergy in this low-avidity autoreactive population,
contributing to their relative resistance to apoptotic
tolerance mechanisms.
These studies illustrate simultaneous and dual me-
chanisms of antigen-specific tolerance to diabetes-asso-
ciated autoantigens. The first, most fundamental level of
control is a genetically determined threshold for central
tolerance through deletion of high-avidity autoreactive
T cells. The relationship between specific INS-VNTR
alleles and levels of proinsulin tetramer-binding CD4
T cells, corresponding directly with the previously
observed levels of thymic antigen expression, clearly
identifies this developmental checkpoint as a funda-
mental determinant of T1D susceptibility. This is the first
direct demonstration in human disease of this important
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Figure 3 Partial expression profile of PI-specific, tetramer-sorted cells. Upregulated transcripts for FASLG, tumor necrosis factor (TNF),
TNFSF11 and IL-2, which are commonly associated with peripheral tolerance, distinguish T1D subjects (a) from control subjects (b). Similar
associations were not observed for control HA306–318-specific cells (c, d). Relative transcript expression was calculated as fold up- or
downregulation in peptide-stimulated cultures relative to autologous non-stimulated cultures. Gene expression profiling was performed on
tetramer-positive cells isolated by flow cytometry using a BD FACSVantage cell sorter (BD Biosciences, San Jose, CA, USA). From the sorted
tetramer-positive cells, total RNA was extracted using a MagMAX Total RNA Isolation Kit (Applied Biosystems, Inc., Foster City, CA, USA).
First-strand complementary DNA was synthesized with the RT
2 first-strand kit (SABiosciences, Corp., Frederick, MD, USA) and samples
plated on RT
2 profiler PCR arrays for common human cytokines (SABiosciences), followed by the amplification by real-time PCR on a
StepOne Plus or an ABI7000 sequence detection system (Applied Biosystems, Inc.). Amplification was carried out in a total volume of 25ml for
40 cycles of 15s at 951C and 1min at 601C each. Expression of each gene was determined by normalizing the expression to five housekeeping
genes. Relative gene expression for each subject was calculated by comparing peptide-stimulated samples to an unstimulated autologous
sample to calculate a fold-change value.
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Genes and Immunitycentral control of antigen-specific autoimmunity, but it is
functionally incomplete. Using the modified ‘9S’ agonist
tetramer, we also identified low-avidity autoreactive T
cells in the peripheral circulation, which were survivors
that had escaped central thymic deletion. In our control,
non-diabetic subjects, transcript profiling of these cells
suggested a second peripheral tolerance mechanism
characterized by upregulation of pro-apoptotic genes.
Thus, both central and peripheral deletional checkpoints
are invoked to control T-cell autoreactivity to proinsulin,
manifest through genetic control of antigen expression
and the avidity threshold for antigen-specific response.
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